A Rare Case of Famotidine-Induced Delirium in a Peritoneal Dialysis Patient

Perit Dial Int. 2017;37(1):118-120. doi: 10.3747/pdi.2016.00145.

Abstract

H2 receptor antagonists are commonly employed to manage gastro-esophageal reflux and peptic ulcer diseases with a very low incidence of side effects. Herein, we report an extremely rare incidence of famotidine-induced acute confusion in a patient with end-stage renal failure. We also discuss the pharmacokinetic properties of famotidine and its interplay with compromised renal function to result in neuropsychiatric manifestations, highlighting the importance of dosage ad ustment in individuals with renal insufficiency.

Keywords: Delirium; H2 receptor antagonists; end-stage renal failure; famotidine; peritoneal dialysis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acute Disease
  • Delirium / chemically induced*
  • Delirium / physiopathology
  • Dyspepsia / diagnosis
  • Dyspepsia / drug therapy*
  • Famotidine / adverse effects*
  • Famotidine / therapeutic use
  • Follow-Up Studies
  • Humans
  • Kidney Failure, Chronic / diagnosis
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Peritoneal Dialysis / adverse effects*
  • Peritoneal Dialysis / methods
  • Risk Assessment
  • Treatment Outcome
  • Withholding Treatment

Substances

  • Famotidine